Rare disease news, mapped to the diseases behind the headlines. AI-classified across pipeline, policy, funding, science, and community.
Be among the first to receive Kisho Intelligence Briefings
Showing news related to
Showing 1–2 of 2 stories
The biopharma industry is increasingly focused on the weight loss sector, projected to surpass $130 billion by 2035. Analysts anticipate significant developments in the oral market and novel mechanisms as 2026 approaches.
Read full storyThe CDC reports that the Southeast, Appalachia, and certain tribal lands have the highest rates of obesity and diabetes in the U.S. This data highlights significant health disparities that may require targeted public health interventions.
Get the week's most important rare disease developments — pipeline moves, policy changes, and funding signals — delivered to your inbox every Monday.
Free weekly briefing. Unsubscribe anytime.